Biomerica (BMRA) Accounts Payables (2011 - 2026)

Biomerica (BMRA) has 16 years of Accounts Payables data on file, last reported at $730000.0 in Q1 2026.

• For the quarter ending Q1 2026, Accounts Payables rose 15.51% year-over-year to $730000.0; the trailing twelve-month figure through Feb 2026 stood at $730000.0 (up 15.51% YoY), and the FY2025 full-year result was $672000.0, down 40.95% from the prior year.
• Accounts Payables eased to $730000.0 in Q1 2026, from $740000.0 in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $2.6 million in Q1 2022 to a low of $344000.0 in Q2 2023.
• A 5-year average of $856728.4 and a median of $730000.0 in 2026 frame the typical range for Accounts Payables.
• Across the five-year window, Accounts Payables jumped 245.02% in 2022 and plunged 85.16% in 2023, its largest moves.
• Tracing BMRA's Accounts Payables over 5 years: stood at $670074.0 in 2022, then grew by 16.85% to $783000.0 in 2023, then rose by 8.3% to $848000.0 in 2024, then decreased by 12.74% to $740000.0 in 2025, then slipped by 1.35% to $730000.0 in 2026.
• Business Quant data shows BMRA's Accounts Payables at $730000.0 in Q1 2026, $740000.0 in Q4 2025, and $681000.0 in Q3 2025.